Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Nipro Corp (8086 JP)
Watchlist
36
Analysis
Health Care
•
Japan
NIPRO CORPORATION manufactures medical products. The Company's products include artificial dialysis and blood transfusion equipment, hypodermic syringes, and glass products for medical use.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
26 Sep 2025 07:42
Japan Morning Connection: AI and Tech Strength Cooling Ahead of Potential Govt Shutdown and EoQ
Memory names took a leg lower, setting a poor tone for JP peers. Medtech names took a hit with potential tarriffs and price capping pressures.
Andrew Jackson
Follow
498 Views
Share
bullish
•
Thematic (Sector/Industry)
•
15 Jun 2025 08:30
APAC Healthcare Weekly (June 15)- CSPC, Wuxi Bio, Samsung Bio, Daiichi Sankyo, SanBio, Cochlear
CSPC entered research collaboration with AstraZeneca. Wuxi Bio is constructing new plant in China. Samsung Bio signed new CDMO contract. Daiichi...
Tina Banerjee
Follow
581 Views
Share
bearish
•
Nintendo
•
14 Jun 2021 14:03
TSE Prime: Japan's Corporate Governance Code Finalized So Boxes Will Be Furiously Ticked
The TSE on Friday announced the revisions to the Governance Code. This codifies the "governance thresholds" required to join TSE Prime next year....
Travis Lundy
Follow
457 Views
Share
bearish
•
Thematic (Sector/Industry)
•
25 Jun 2020 13:50
🇯🇵 JAPAN - Stress Tests Part 4 - From Free Cash Flow to Change in Cash
FROM FREE CASH FLOW TO CHANGE IN CASH - In Parts 2 and 3 of this series, we covered Operating Cash Flow, Fixed Asset Cash Flow and Inventory Cash...
Campbell Gunn
Follow
641 Views
Share
bearish
•
Thematic (Sector/Industry)
•
07 Apr 2020 13:38
🇯🇵 JAPAN • Dividends At Risk - The Serial 'Cutters'
DIVIDENDS AT RISK - As noted in our daily Results & Revisions Updates in the last few days, Japanese companies are starting to shore up their...
Campbell Gunn
Follow
631 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x